Last updated 25/03/2025
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| State Consortium in the Network for the Development of Advanced Therapy Drugs (CERTERA) Gene therapy |
| CERT22/00004 |
| Pardo Jimeno, Julián |
| 50.000.00 € |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Exploring the link between emerging additives and cardiovascular disease in a cohort, during 10-year follow-up. Subproject 1. Artificial sweeteners in serum and progression of subclinical atherosclerosis |
| PI24/00479 |
| Moreno Franco, Mª Belen |
| 01/01/2025 - 31/12/2027 |
| 208.437,50 € |
| ISC III |
| Design and validation of a patient experience questionnaire regarding nursing care: A multicenter cross-sectional study |
| PI24/00943 |
| López Ibort, Mª Nieves |
| 01/01/2025 - 31/12/2027 |
| 26.000,00 € |
| ISC III |
| Immunotargeted tools for the diagnosis, monitoring, and treatment of soft tissue sarcomas based on nanobodies against CD276 and GD2 |
| PI24/00969 |
| Jiménez Schuhmacher, Alberto |
| 01/01/2025 - 31/12/2027 |
| 177.500,00 € |
| ISC III |
| Single-center randomized intervention study to compare the efficacy and safety of daylight photodynamic therapy with methylaminolevulinate, diclofenac 3% gel, and tirbanibulin in actinic cheilitis |
| PI24/01091 |
| Gilaberte Calzada, Yolanda |
| 01/01/2025 - 31/12/2027 |
| 97.500,00 € |
| ISC III |
| Integrated Metabolomic and Multimodal Imaging Analysis for the Identification of Predictive Biomarkers of Development, Progression, and Therapeutic Response in Diabetic Macular Edema |
| PI24/01249 |
| Pinilla Lozano, Isabel |
| 01/01/2025 - 31/12/2027 |
| 22.500,00 € |
| ISC III |
| "Effect of obstructive sleep apnea diagnosis and treatment on health outcomes in patients hospitalized with COPD. A randomized clinical trial." |
| PI24/01470 |
| Marín Oto, Marta |
| 01/01/2025 - 31/12/2027 |
| 108.500,00 € |
| ISC III |
| Artificial Intelligence Platform to Support Clinical Decision-Making in Liver Transplantation |
| PI24/01966 |
| Serrano Aulló, Trinidad |
| 01/01/2025 - 31/12/2027 |
| 129.375,00 € |
| ISC III |
| Influence of genetic factors associated with HDL cholesterol on the metabolomic profile and incidence of cardiovascular disease |
| PI24/02054 |
| Jarauta Simón, Estíbaliz |
| 01/01/2025 - 31/12/2027 |
| 56.250,00 € |
| ISC III |
| "ALK pathway inhibition as a novel therapeutic strategy to combat immunoevasion and chemoresistance in pancreatic ductal adenocarcinoma" |
| PI23/00142 |
| Sancho Andrés, Patricia |
| 01/01/2024 - 31/12/2026 |
| 190.000,00 € |
| ISC III |
| Toward Precision Medicine: Exposome and Omics Analysis Using eXplicable Artificial Intelligence to Study Their Lifespan Impact on Obesity, Insulin Resistance, and Metabolic Health. EXOMAIR |
| PI23/00191 |
| Bueno Lozano, María Gloria |
| 01/01/2024 - 31/12/2026 |
| 28.750,00 € |
| ISC III |
| Identification of blood cell-derived diagnostic biomarkers in colorectal cancer |
| PI23/00447 |
| Piazuelo Ortega, Elena |
| 01/01/2024 - 31/12/2026 |
| 108.750,00 |
| ISC III |
| Usefulness of intra-abdominal pressure and clinical ultrasound in guiding diuretic therapy in patients with acute heart failure |
| PI23/00797 |
| Rubio Gracia, Jorge |
| 01/01/2024 - 31/12/2026 |
| 77.500,00 |
| ISC III |
| Evaluation of axonal and microvascular alterations in patients with persistent COVID by neuro-ophthalmological study with optical coherence tomography (OCT) and OCT angiography |
| PI23/00935 |
| García Martín, Elena |
| 01/01/2024 - 31/12/2026 |
| 33.750,00 |
| ISC III |
| Phenotypic characterization of gestational diabetes: personalized approach to short- and medium-term maternal-fetal complications (Pheno-GestDM) |
| PI23/01112 |
| Paules Tejero, Cristina |
| 01/01/2024 - 31/12/2026 |
| 89.375,00 |
| ISC III |
| Cornelia de Lange Spectrum, Towards Precision Medicine: Integration of omics data, longitudinal follow-up and ontogenetic study |
| PI23/01370 |
| Ramos Fuentes, Feliciano |
| 01/01/2024 - 31/12/2026 |
| 90.000,00 |
| ISC III |
| Cardiovascular health and lifestyle in Aragonese adolescents (CHIARA study) |
| PI23/01771 |
| Altaba Church, Iris |
| 01/01/2024 - 31/12/2026 |
| 52.500,00 |
| ISC III |
| Development of a rapid urine diagnostic test for placental dysfunction. (POCT-PLACENTA) |
| PI22/00143 |
| Orós López, Daniel |
| 01/01/2023 - 31/12/2025 |
| 78.650,00 |
| ISC III |
| Assessment of gastric cancer risk and prognosis using an exome-based genetic score. Interaction with environmental factors and Helicobacter pylori infection. |
| PI22/00537 |
| García González, Asunción |
| 01/01/2023 - 31/12/2025 |
| 171.820,00 |
| ISC III |
| Multimorbidity in the National Health System: Population characterization and impact of its patterns and trajectories in older people (MM-SNS Project) |
| PI22/00701 |
| Prados Torres, Alexandra |
| 01/01/2023 - 31/12/2025 |
| 52.030,00 |
| ISC III |
| Analysis of differential factors associated with the presence of persistent symptoms in people diagnosed with covid 19: Case-control studies |
| PI22/01070 |
| Magallón Botaya, Rosa Mª |
| 01/01/2023 - 31/12/2025 |
| 62.920,00 |
| ISC III |
| Analysis of the impact of the pandemic on the use of health services through the application of mixed methods in the cohort |
| PI22/01193 |
| Bad Fumanal, Sara |
| 01/01/2023 - 31/12/2025 |
| 93.170,00 |
| ISC III |
| DIVERSE - Disentangling the Interplay between behaViours and biomarkERS across the lifeEspan |
| PI22/01337 |
| Moreno Aznar, Luis Alberto |
| 01/01/2023 - 31/12/2025 |
| 39.930,00 |
| ISC III |
| Prognostic Biomarkers for Advanced Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatocellular Carcinoma (HCC) in Obese Individuals |
| PI22/01366 |
| Arbonés Mainar, José Miguel |
| 01/01/2023 - 31/12/2025 |
| 123.420,00 |
| ISC III |
| Evaluation of the pathogenic role of granzyme A in urinary sepsis due to E. coli |
| PI22/01439 |
| Cloth Pardo, José Ramón |
| 01/01/2023 - 31/12/2025 |
| 129.107,00 |
| ISC III |
| Study of the genetic variability in SCARB1 and its relationship with the functionality in the binding of high-density lipoproteins (HDL) |
| PI22/01595 |
| Civeira Murillo, Fernando |
| 01/01/2023 - 31/12/2025 |
| 62.920,00 |
| ISC III |
| The immuno-reactive microenvironment of lung metastases from colorectal cancer: a therapeutic opportunity |
| PI22/01938 |
| Sanz Pamplona, Rebeca |
| 01/01/2023 - 31/12/2025 |
| 75.020,00 |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Porous scaffolds functionalized with exosomes as a tumor cell capture tool (TCCap) |
| DTS21/00130 |
| Martín Duque, María del Pilar |
| 01/01/2022 - 31/12/2023 |
| 67.100,00 |
| ISC III |
| Oxidative phosphorylation genetic disorders: pathological mechanisms and therapeutic approaches |
| PI21/00229 |
| Ruiz Pesini, Eduardo |
| 01/01/2022 - 31/12/2024 |
| 203.280,00 |
| ISC III |
| Epigenetics in the ALS-FTD spectrum: understanding phenotypic variability and new advances in personalized medicine. (II) |
| PI21/00372 |
| Osta Pinzolas, Rosario |
| 01/01/2022 - 31/12/2024 |
| 124.630,00 |
| ISC III |
| Diagnosis and personalized monitoring of patients at risk of digestive tumor pathology through Thermal Liquid Biopsy (TLB) applying artificial intelligence and nanotechnology tools |
| PI21/00394 |
| Abián Franco, Olga María |
| 01/01/2022 - 31/12/2024 |
| 105.270,00 |
| ISC III |
| Effects of electroporation and electrochemotherapy on the localized destruction of liver tumors in an experimental porcine model |
| PI21/00440 |
| Güemes Sánchez, Antonio |
| 01/01/2022 - 31/12/2024 |
| 99.220,00 |
| ISC III |
| Development of tools based on nanoantibodies against CD276 and ABCC3 for the diagnosis and treatment of pancreatic ductal adenocarcinoma |
| PI21/00441 |
| Jiménez Schuhmacher, Alberto |
| 01/01/2022 - 31/12/2024 |
| 159.720,00 |
| ISC III |
| In Vitro Liver Tissue Morphogenesis: Addressing Critical Challenges Towards Effective Generation of Bioengineered Livers |
| PI21/00667 |
| Baptista, Pedro Miguel |
| 01/01/2022 - 31/12/2024 |
| 196.020,00 |
| ISC III |
| Validation in Spanish of an instrument for measuring emotional health in children and adolescents diagnosed with type 1 diabetes mellitus in Spain |
| PI21/00708 |
| Casanovas Marsal, Josep Oriol |
| 01/01/2022 - 31/12/2024 |
| 16.940,00 |
| ISC III |
| Development of advanced nanomaterials for the controlled release of drugs and target molecules for the treatment of osteoarthritis |
| PI21/00911 |
| Mendoza Cantos, Gracia María |
| 01/01/2022 - 31/12/2024 |
| 129.470,00 |
| ISC III |
| Rapalogs and biguanides in adjuvant with photodynamic therapy modulating the tumor microenvironment of actinic keratosis and squamous cell carcinoma in situ in transplant patients |
| PI21/00953 |
| Gilaberte Calzada, Yolanda |
| 01/01/2022 - 31/12/2024 |
| 64.130,00 |
| ISC III |
| Efficacy and implementation of an online psychotherapy program to prevent the effects of the COVID-19 pandemic on the mental health of social and health professionals |
| PI21/01338 |
| López Del Hoyo, Yolanda |
| 01/01/2022 - 31/12/2024 |
| 36.300,00 |
| ISC III |
| Cov-racap Project: Analysis of the symptoms and quality of life of people diagnosed with Persistent COVID-19, and the effectiveness of Health Asset Recommendations from Primary Care. |
| PI21/01356 |
| Oliván Blázquez, Bárbara |
| 01/01/2022 - 31/12/2024 |
| 47.795,00 |
| ISC III |
| Dysregulation of PLAGL1 as a risk factor for preterm labor and preterm birth |
| PI21/01748 |
| Schoorlemmer, Jon |
| 01/01/2022 - 31/12/2024 |
| 123.420,00 |
| ISC III |
| Non-alcoholic fatty liver disease in patients with inflammatory bowel disease. Experimental study of the role of the intestinal microbiota |
| PI21/01907 |
| Gomollón García, Fernando |
| 01/01/2022 - 31/12/2024 |
| 99.220,00 |
| ISC III |
| Association of the cardiac pulse response to apnea with the development of atheromatous plaques. Role of exosomal microRNAs |
| PI21/01954 |
| Marín Trigo, José María |
| 01/01/2022 - 31/12/2024 |
| 164.560,00 |
| ISC III |
| Development and validation of an early diagnosis protocol for visual impairment of cerebral origin for children born with extreme prematurity |
| PI21/01977 |
| Pueyo Royo, Victoria |
| 01/01/2022 - 31/12/2024 |
| 32.670,00 |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Precision medicine and advanced diagnostics for Stargardt disease in Spain: Diagnostic tools using genetic biomarkers, imaging, and artificial intelligence analysis. StargSpain |
| PMPER24/00022 |
| Pinilla Lozano, Isabel |
| 01/01/2025 - 31/12/2026 |
| 1.167.650,00 |
| ISC III |
| Early Phase Clinical Trials Unit in Oncology (UFPO) |
| UICM24/00025 |
| Pazo Cid, Roberto Antonio |
| 01/01/2025 - 31/12/2026 |
| 1.108.838,51 |
| ISC III |
| Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) |
| RD24/0005/0004 |
| Magallón Botaya, Mª Rosa |
| 01/01/2025 - 31/12/2027 |
| 324.280,00 |
| ISC III |
| Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) |
| RD24/0005/0013 |
| Gimeno Miguel, Antonio |
| 01/01/2025 - 31/12/2027 |
| 237.160,00 |
| ISC III |
| Inflammation and immunopathology of the visual system |
| RD24/0007/0022 |
| García Martín, Elena |
| 01/01/2025 - 31/12/2027 |
| 139.150,00 |
| ISC III |
| Spanish network in maternal, neonatal, child and developmental health research (RICORS-SAMID) |
| RD24/0013/0022 |
| Rodríguez Martínez, Gerardo |
| 01/01/2025 - 31/12/2027 |
| 141.570,00 |
| ISC III |
| TERAV+ |
| RD24/0014/0015 |
| Sánchez Martínez, Diego |
| 01/01/2025 - 31/12/2027 |
| 67.711,60 |
| ISC III |
| Personalization and planning of cytoreductive surgery using radiomics and artificial intelligence to improve the accuracy of estimating the Peritoneal Carcinomatosis Index |
| PMPTA23/00041 |
| Borrego Estella, Vicente |
| 01/01/2024 - 31/12/2025 |
| 147.620,00 |
| ISC III |
| Marginal organ regeneration with ex vivo cell therapy in prolonged normothermic perfusion for elderly patients with chronic and oncological diseases |
| PMPTA23/00047 |
| Baptista, Pedro Miguel |
| 01/01/2024 - 31/12/2025 |
| 668.425,73 |
| ISC III |
| P4COPD: Prediction, Prevention, Personalized and Precision management of COPD in young adults |
| PMP21/00090 |
| Marín Trigo, José María |
| 13/06/2024 - 31/12/2025 |
| 70.785,00 |
| ISC III |
| Public health and preventive precision medicine combining physical examination, lifestyle habits, and genomic information: monitoring the obesity pandemic through the IMPaCT Cohort extension (Obes-IMPaCT) |
| PMP22/00003 |
| Sons Larraz, Luis Alfonso |
| 22/12/2024 - 31/12/2025 |
| 483.450,00 |
| ISC III |
| Withdraw or maintain antiplatelet and anticoagulants to perform polypectomy of non-pedunculated lesions of less than one centimeter with a cold snare: hemorrhagic and thrombotic risk |
| ICI22/00054 |
| Lanas Arbeloa, Angel |
| 01/01/2023 - 31/12/2026 |
| 121.550,00 |
| ISC III |
| PREDIMIGRAINE: Precision medicine to prevent migraine chronification through the prediction of pain attacks and response to treatment with anti-CGRP antibodies using multi-omics strategies |
| PMP22/00179 |
| Santos Lasaosa, Sonia |
| 01/01/2023 - 31/12/2026 |
| 100.001,00 |
| ISC III |
| Randomized, Double-Blind, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Topical Metformin in Adjuvant With Daylight Photodynamic Therapy in Actinic Keratoses |
| ICI21/00031 |
| Gilaberte Calzada, Yolanda |
| 01/01/2022 - 31/12/2025 |
| 168.831,85 |
| ISC III |
| Mild-moderate respiratory symptoms in patients with persistent COVID-19: clinical trial and biological characterization of montelukast (E-SPERANZA COVID) |
| ICI21/00058 |
| Magallón Botaya, Rosa Mª |
| 01/01/2022 - 31/12/2025 |
| 39.463,60 |
| ISC III |
| Therapeutic targets and biomarkers from precision medicine in MAFLD (PreMed-MAFLD) |
| PMP21/00094 |
| Arbonés Mainar, José Miguel |
| 01/01/2022 - 31/12/2025 |
| 134.750,00 |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| BELONGING TO THE INFRASTRUCTURE OF PRECISION MEDICINE ASSOCIATED WITH SCIENCE AND TECHNOLOGY (IMPaCT) |
| IFEQ21/00206 |
| Lanas Arbeloa, Angel |
| 01/01/2022 - 31/12/2023 |
| 401.000,00 |
| ISC III |
| Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) |
| RD21/0016/0005 |
| Magallón Botaya, Rosa Mª |
| 01/01/2022 - 31/12/2024 |
| 287.248,50 |
| ISC III |
| Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) |
| RD21/0016/0019 |
| Prados Torres, Alexandra |
| 01/01/2022 - 31/12/2024 |
| 287.248,50 |
| ISC III |
| Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS) |
| RD21/0016/0023 |
| Bernal Delgado, Enrique |
| 01/01/2022 - 31/12/2024 |
| 287.248,50 |
| ISC III |
| Inflammation and immunopathology organs and systems. Inframmatory diseases network |
| RD21/0002/0050 |
| Pablo Julvez, Luis Emilio |
| 01/01/2022 - 31/12/2024 |
| 175.245,40 |
| ISC III |
| Primary care interventions to prevent maternal and child chronic diseases of perinatal and developmental origin |
| RD21/0012/0012 |
| Rodríguez Martínez, Gerardo |
| 01/01/2022 - 31/12/2024 |
| 124.080,00 |
| ISC III |
| Flow Cytometer Analyzer and Separator |
| IFEQ22/00058 |
| Pablo Julvez, Luis Emilio |
| 01/01/2023 - 31/12/2024 |
| 400.000,00 |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| ISCIII Platform for the revitalization and innovation of the SNS's industrial capabilities and their effective transfer to the productive sector |
| PT23/00070 |
| Pablo Júlvez, Luis Emilio |
| 01/01/2024 - 31/12/2026 |
| 327.120,00 |
| ISC III |
| ISCIII Clinical Research Support Platform - SCReN |
| PT23/00164 |
| Lanas Arbeloa, Angel |
| 01/01/2024 - 31/12/2026 |
| 280.720,00 |
| ISC III |
| Preclinical Support Platform of the IIS Aragón |
| PT23/00186 |
| Ochoa Garrido, Ignacio |
| 01/01/2024 - 31/12/2026 |
| 313.490,00 |
| ISC III |
| FORT23/00028/01 Digestive Pathology Group |
| FORT23/00028/01 |
| Lanas Arbeloa, Angel |
| 01/01/2024 - 31/12/2027 |
| 419.870,00 |
| ISC III |
| FORT23/00028/02_Tissue Microenvironment Lab Group |
| FORT23/00028/02 |
| Ochoa Garrido, Ignacio |
| 01/01/2024 - 31/12/2027 |
| 412.610,00 |
| ISC III |
| FORT23/00028/03_Immunotherapy, Inflammation and Cancer Group |
| FORT23/00028/03 |
| Pardo Jimeno, Julián |
| 01/01/2024 - 31/12/2027 |
| 416.240,00 |
| ISC III |
| FORT23/00028/04_Nanostructured Surfaces and Particles Group |
| FORT23/00028/04 |
| Santamaria Ramiro, Jesús Marcos |
| 01/01/2024 - 31/12/2027 |
| 418.055,00 |
| ISC III |
| FORT23/00028/05_Advanced Materials in Biomedicine Group |
| FORT23/00028/05 |
| Mendoza Cantos, Gracia María |
| 01/01/2024 - 31/12/2027 |
| 412.005,00 |
| ISC III |
| FORT23/00028/06_Maternal and Fetal Health Group |
| FORT23/00028/06 |
| Paules Tejero, Cristina |
| 01/01/2024 - 31/12/2027 |
| 414.645,22 |
| ISC III |
| Eva RAps: Development of a model of evaluation indicators for Health Asset Recommendations schemes in Primary Care |
| PI20/00264 |
| Melús Palazón, Elena |
| 01/01/2021 - 30/06/2025 |
| 60.000,00 € |
| ISC III |
| Implementation, effectiveness and cost-effective study of the Unified Protocol in blended format for transdiagnostic treatment of emotional disorders in the Spanish National Health System |
| PI20/00697 |
| Osma López, Jorge Javier |
| 01/01/2021 - 30/06/2025 |
| 42.000,00 € |
| ISC III |
| Development of a risk calculator for the onset of diabetic retinopathy based on multimodal imaging techniques in type 1 diabetic patients |
| PI20/00740 |
| Pinilla Lozano, Isabel |
| 01/01/2021 - 30/04/2025 |
| 32.700,00 € |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| MARKING SYSTEM BASED ON NANOPARTICLES FOR THE DETECTION OF METASTATED AXILLARY NODES IN PATIENTS WITH BREAST CANCER AFTER NEOADJUVANT CHEMOTHERAPY |
| DTS20/00131 |
| Güemes Sánchez, Antonio |
| 01/01/2021 - 31/12/2023 |
| 43.000,00 € |
| ISC III |
| Neuroretina as an early biomarker of progression from mild cognitive impairment to Alzheimer's and protective effect of cognitive-visual rehabilitation in the progression of dementia |
| PI20/00437 |
| García Martín, Elena |
| 01/01/2021 - 31/12/2023 |
| 22.000,00 € |
| ISC III |
| New metabolic biomarkers for the stratification and clinical management of pancreatic cancer |
| PI20/00921 |
| Sancho Andrés, Patricia |
| 01/01/2021 - 31/12/2023 |
| 107.000,00 € |
| ISC III |
| OMICS AND ARTIFICIAL INTELLIGENCE AS TOOLS TO UNDERSTAND MOLECULAR MECHANISMS OF INSULIN RESISTANCE IN OBESE CHILDREN DURING PUBERTY |
| PI20/00988 |
| Bueno Lozano, María Gloria |
| 01/01/2021 - 31/12/2023 |
| 35.000,00 € |
| ISC III |
| Effect of obesity on acetylation of COX-1 by aspirin as biomarker of efficacy in chemmoprevention and co-therapy of colorectal cancer: a phase 2 |
| PI20/01514 |
| Sostres Homedes, Carlos |
| 01/01/2021 - 31/12/2023 |
| 182.000,00 € |
| ISC III |
| Support platform for clinical research |
| PT20/00076 |
| Lanas Arbeloa, Angel |
| 01/01/2021 - 31/12/2023 |
| 199.650,00 |
| ISC III |
| Clinical efficacy and bacteriological eradication of 4 short-course antibiotic regimens for lower urinary tract infections in adult women. (SCOUT Studio) |
| ICI20/00119 |
| Sánchez Calavera, Mª Antonia |
| 01/01/2021 - 31/12/2024 |
| 82.500,00 |
| ISC III |
| Impact of the threat of premature birth on cardiovascular and metabolic programming from fetal life to childhood. |
| PI20/00741 |
| Paules Tejero, Cristina |
| 01/01/2021 - 31/12/2024 |
| 35.500,00 € |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Analysis of soluble markers of immune activation and NK and CD8 T cell populations in patients with SARS-CoV-2 infection |
| COV20/00308 |
| Julián Pardo Jimeno and José Ramón Paño Pardo |
| 01/05/2020 - 31/07/2020 |
| 276.000,00 € |
| ISC III |
| Prognostic variables, resources consumed and cost in Primary Care of patients with COVID-19 |
| COV20/00634 |
| Rosa Magallón Botaya |
| 01/05/2021 - 30/10/2021 |
| 26.000,00 € |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Design and development of a new phenylalanine test for the family management of phenylketonuria |
| DTS19/00045 |
| Sancho Sanz, Javier |
| 01/01/2020 - 31/12/2021 |
| 66.000,00 € |
| ISC III |
| DEVELOPMENT OF A DEVICE TO EXPLORE VISUAL FUNCTION IN CHILDREN AND NON-COOPERATIVE PATIENTS (DIVE) |
| DTS18/00068 |
| Pueyo Royo, María Victoria |
| 01/01/2019 - 31/12/2021 |
| 41.500,00 € |
| ISC III |
| Development of a novel index to predict the risk of global dementia and subtypes at 5, 10 and 20 years in Primary Care, using statistical models of competitive risks, based on lifestyle variables and psychopathological risk factors |
| PI19/01874 |
| Santabárbara Serrano, Javier; From the Left Chamber, Concepción |
| 01/01/2020 - 31/12/2022 |
| 18.000,00 € |
| ISC III |
| Thermal Liquid Biopsy (BLT): Clinical application of serum calorimetric curve analysis as a new method of diagnosis and monitoring of digestive tumor pathology |
| PI18/00349 |
| Abián Franco, Olga María |
| 01/01/2019 - 31/12/2022 |
| 165.750,00 € |
| ISC III |
| Design and validation of a decision support tool for empirical antibiotic therapy based on deep learning with patients with bacteremia |
| PI18/00527 |
| Cloth Pardo, José Ramón |
| 01/01/2019 - 30/06/2023 |
| 132.000,00 € |
| ISC III |
| Development of a technological platform for the bioengineering of human livers for transplantation in paracetamol-induced acute liver failure in immunodeficient pigs |
| PI18/00529 |
| Baptista -, Pedro Miguel |
| 01/01/2019 - 30/06/2023 |
| 137.000,00 € |
| ISC III |
| Mediterranean LIfestyle in Pediatric Obesity Prevention (MELI-POP) |
| PI18/00666 |
| Moreno Aznar, Luis Alberto |
| 01/01/2019 - 30/06/2023 |
| 63.000,00 € |
| ISC III |
| Effectiveness of vitamin D and metformin as adjuvants to PDT and ingenol mebutate in the treatment of non-melanoma skin cancer: a tumor and stromal approach |
| PI18/00858 |
| Gilaberte Calzada, Yolanda |
| 01/01/2019 - 31/12/2022 |
| 48.000,00 € |
| ISC III |
| Getting sick is human: when the patient is the doctor. |
| PI18/00968 |
| Altisent Trota, Rogelio |
| 01/01/2019 - 30/06/2023 |
| 21.000,00 € |
| ISC III |
| Effectiveness and cost-effectiveness of two Mediterranean Lifestyle and Mindfulness programs in the prevention and treatment of mild and moderate subclinical depression in Primary Care. |
| PI18/01336 |
| Oliván Blázquez, Bárbara |
| 01/09/2019 - 31/12/2022 |
| 42.000,00 € |
| ISC III |
| Prevention of depression in the workplace through a personalized intervention based on risk algorithms, ICTs and decision support systems: a randomized controlled trial |
| PI18/01653 |
| Alda Díez, Marta María |
| 01/01/2019 - 30/06/2023 |
| 21.200,00 € |
| ISC III |
| Virtual biopsy: development of immunotargeted tools for non-invasive diagnosis of pancreatic ductal adenocarcinoma |
| PI18/01665 |
| Jiménez Schuhmacher, Alberto |
| 01/01/2019 - 31/12/2022 |
| 92.000,00 € |
| ISC III |
| Development of an automated field scan test for children |
| PI18/01869 |
| Pueyo Royo, Victoria |
| 01/01/2019 - 30/06/2023 |
| 97.000,00 € |
| ISC III |
| Analysis of atherosclerosis plaques using ultrasound: high-risk criteria |
| PI18/01929 |
| Jarauta Simón, Estíbaliz |
| 01/01/2019 - 30/06/2023 |
| 52.000,00 € |
| ISC III |
| Exosomal miRNA profile in obstructive sleep apnea and its relationship with atherosclerosis and accelerated vascular senescence. |
| PI18/01524 |
| Marín Trigo, José María |
| 01/01/2019 - 31/12/2021 |
| 67.000,00 € |
| ISC III |
| Sequential screening for preeclampsia using angiogenic markers in the first trimester |
| PI19/00692 |
| Orós López, Daniel |
| 01/01/2020 - 31/12/2023 |
| 80.750,00 € |
| ISC III |
| Influence of genetic and environmental factors on the development of T2DM: identification of metabolic mechanisms mediating this effect. |
| PI19/00694 |
| Civeira Murillo, Fernando; Mateo Gallego, Rocio |
| 01/01/2020 - 31/12/2023 |
| 117.000,00 € |
| ISC III |
| Evaluation of the implementation of an online psychological therapy program for the treatment of depression in primary care: A hybrid study design. |
| PI19/00805 |
| García Campayo, José Javier |
| 01/01/2020 - 31/12/2023 |
| 21.000,00 € |
| ISC III |
| Redefining the Cornelia de Lange spectrum by integrating new clinical, genomic, transcriptomic, and metabolomic data. |
| PI19/01860 |
| Pie Juste, Juan; Ramos Fuentes, Feliciano |
| 01/01/2020 - 31/12/2023 |
| 80.000,00 € |
| ISC III |
| Thyroid hormone resistance and its relationship with diabetes and cardiovascular and metabolic risk. From the laboratory to the clinic, epidemiology, and Big Data. |
| PI19/00020 |
| Laclaustra Gimeno, Martín |
| 01/01/2020 - 30/06/2024 |
| 76.000,00 € |
| ISC III |
| Surgical treatment of colorectal cancer: analysis of the influence of an intensified recovery protocol on long-term oncological outcomes. |
| PI19/00291 |
| Ramírez Rodríguez, José Manuel |
| 01/01/2020 - 30/06/2024 |
| 31.000,00 € |
| ISC III |
| Study of healthy cognitive aging in a cohort of workers: Influence of lifestyles, vascular factors and mental health |
| PI19/00948 |
| Moreno Franco, M Belen; School Wolf, Elena |
| 01/01/2020 - 30/06/2024 |
| 37.000,00 € |
| ISC III |
| DESVELA Cohort. Analysis of the role of personal aptitudes as determinants of behaviors, quality of life, health outcomes, and mortality. |
| PI19/01076 |
| Magallón Botaya, Rosa Mª |
| 01/01/2020 - 30/06/2024 |
| 22.540,00 € |
| ISC III |
| Evaluate GPS (Evaluate and Apply Health Promotion Practice Guides): Project to evaluate the implementation of the evaluation of the NICE NG44 guideline |
| PI19/01079 |
| Benede Azagra, Bethlehem |
| 01/01/2020 - 30/06/2024 |
| 43.500,00 € |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Study of the role of lipid metabolism in pancreatic cancer using avatar mice established from solid and liquid biopsies. |
| PI17/00082 |
| Sancho Andrés, Patricia |
| 01/01/2018 - 31/12/2021 |
| 112.000,00 € |
| ISC III |
| Prenatal exposure to oxphos xenobotics and late-onset parkinson's disease |
| PI17/00166 |
| Ruiz Pesini, Eduardo |
| 01/01/2018 - 31/12/2021 |
| 225.750,00 € |
| ISC III |
| Aspirin and lower gastrointestinal bleeding. Protective effect of probiotics. |
| PI17/00301 |
| Sostres Homedes, Carlos |
| 01/01/2018 - 31/12/2021 |
| 18.000,00 € |
| ISC III |
| Efficacy of the Unified Protocol for the transdiagnostic treatment of emotional disorders in group format: An efficient proposal for the public mental health system |
| PI17/00320 |
| Osma López, Jorge Javier |
| 01/01/2018 - 31/12/2021 |
| 73.900,00 € |
| ISC III |
| Mutations in mitochondrial and nuclear DNA associated with mitochondrial diseases: Confirmation of pathogenicity and therapeutic possibilities |
| PI17/00021 |
| Montoya Villarroya, July |
| 01/01/2018 - 30/06/2022 |
| 232.000,00 € |
| ISC III |
| Virtual Rehabilitation Systems for Weight-Bearing Asymmetry in Patients with Neurological Disorders. |
| PI17/00465 |
| Albiol Pérez, Sergio |
| 01/01/2018 - 30/06/2022 |
| 112.000,00 € |
| ISC III |
| Platelets as biomarkers in colorectal cancer: study of the transcriptome, proteome and platelet activation markers. |
| PI17/02171 |
| Piazuelo Ortega, Elena |
| 01/01/2018 - 30/06/2022 |
| 62.000,00 € |
| ISC III |
| Inflammation and angiogenesis in preterm labor: the impact of threatened preterm labor |
| PI17/02208 |
| Schoorlemmer -, Jon |
| 01/01/2018 - 30/06/2022 |
| 77.000,00 € |
| ISC III |
| Adipose tissue expandability: A longitudinal study and cell therapy for fatty liver disease. |
| PI17/02268 |
| Arbonés Mainar, José Miguel |
| 01/01/2018 - 30/06/2022 |
| 52.000,00 € |
| ISC III |
| Evaluation of direct-acting biomarkers of aspirin for the development of personalized chemoprevention in colorectal cancer |
| PI17/1109 |
| Lanas Arbeloa, Angel |
| 01/01/2018 - 30/06/2022 |
| 140.000,00 € |
| ISC III |
| New biomarkers in ALS: somatic mutations, neuroinflammation and RNA metabolism (II) |
| PI17/00949 |
| Osta Pinzolas, Rosario |
| 01/01/2018 - 31/12/2021 |
| 77.000,00 € |
| ISC III |
| Neuro-ophthalmological evaluation as a diagnostic, evolutionary and prognostic biomarker in the course of multiple sclerosis |
| PI17/01726 |
| García Martín, Elena |
| 01/01/2018 - 31/12/2021 |
| 73.000,00 € |
| ISC III |
| Hypotensive and neuroprotective effect of sustained release formulations in Laponite clay after intravitreal administration in an animal model of optic nerve degeneration |
| PI17/01946 |
| Polo Llorens, Vicente |
| 01/01/2018 - 31/12/2021 |
| 52.000,00 € |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Research Network in Health Services in Chronic Diseases-REDISSEC |
| RD16/0001/0005 |
| Prados Torres, María Alexandra |
| 01/01/2017 - 31/12/2022 |
| 40.205,00 € |
| ISC III |
| Research Network on Preventive Activities and Health Promotion in Primary Care |
| RD16/0007/0005 |
| García Campayo, José Javier |
| 01/01/2017 - 30/06/2022 |
| 151.415,00 € |
| ISC III |
| MATERNAL-CHILD HEALTH AND DEVELOPMENT NETWORK |
| RD16/0022/0013 |
| Rodriguez Martinez, Gerardo |
| 01/01/2017 - 31/12/2022 |
| 153.005,00 € |
| ISC III |
| OFTARED |
| RD16/0008/0029 |
| Pablo Julvez, Luis Emilio |
| 01/01/2017 - 31/12/2021 |
| 23.160,00 € |
| ISC III |
| "ANTORCHA": From the Aragon Workers' Health Study to the Quest for Promoters of Cardiovascular Healthy Aging |
| PIE16/00022 |
| Civeira Murillo, Fernando |
| 01/01/2017 - 30/06/2021 |
| 349.795,00 € |
| ISC III |
| Treatment of early CIR with low molecular weight heparin (TRACIP): randomized clinical trial |
| PI16/00595 |
| Orós López, Daniel |
| 01/01/2017 - 30/06/2021 |
| 45.850,00 € |
| ISC III |
| Psychic and physical comorbidity in the elderly: Incidence, "life-time risk" and implications of "subsyndromic" cases, and "negative" syndromes on mortality rates |
| PI16/00896 |
| From the Left Chamber, Concepción |
| 01/01/2017 - 30/06/2021 |
| 24.000,00 € |
| ISC III |
| Effectiveness of low-intensity internet-supported psychological therapy in patients with multimorbidity in primary care. A controlled clinical trial. |
| PI16/00962 |
| García Campayo, José Javier |
| 01/01/2017 - 31/12/2020 |
| 21.000,00 € |
| ISC III |
| Puberty and metabolic risk in obese children: epigenetic alterations and pathophysiological and diagnostic implications. PUBMEP study |
| PI16/01205 |
| Bueno Lozano, María Gloria |
| 01/01/2017 - 01/01/2021 |
| 16.000,00 € |
| ISC III |
| Characterization of exosomes in patients with suspected STEACS: search for new markers with diagnostic and prognostic value. |
| PI16/02112 |
| García Otín, Ángel Luis |
| 01/01/2017 - 30/06/2021 |
| 65.500,00 € |
| ISC III |
| Optimization of lipid nanoparticles with trail as an antitumor agent |
| PI16/00526 |
| Martínez Lostao, Luis |
| 01/01/2017 - 30/06/2020 |
| 58.500,00 € |
| ISC III |
| Effectiveness of using information and communication technologies in increasing physical activity and losing weight in obese and sedentary subjects. RCT. EVIDENT III study. |
| PI16/00765 |
| González Viejo, Nativity |
| 01/01/2017 - 30/06/2021 |
| 29.700,00 € |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Effectiveness of a patient-centered intervention to improve prescription appropriateness in young elderly patients with multimorbidity and polypharmacy in primary care (Multim-AP Project): Cluster clinical trial |
| PI15/00276 |
| Prados Torres, Alexandra |
| 01/01/2016 - 30/11/2020 |
| 39.000,00 € |
| ISC III |
| Analysis of IS670 differences among members of the Mycobacterium tuberculosis complex and the role of its localization in the origin of replication. |
| PI15/00317 |
| Samper Blasco, Sofia |
| 01/01/2016 - 31/12/2018 |
| 61.500,00 € |
| ISC III |
| Innate and acquired immunity in stomach cancer. Study of gene-gene and gene-environmental factor interactions in disease risk and prognosis. |
| PI15/00331 |
| García González, Asunción |
| 01/01/2016 - 31/12/2018 |
| 51.500,00 € |
| ISC III |
| Ex vivo Re-vascularization in Porcine Liver Bioengineering - A Critical First Step Towards Effective Transplantation of Bioengineered Livers |
| PI15/00563 |
| Baptista -, Pedro Miguel |
| 01/01/2016 - 30/11/2020 |
| 86.500,00 € |
| ISC III |
| Evaluation of the function of KCa3.1 channels in the inflammatory complex induced by Gaucher cells and development of bone complications in GD. Possibility of therapeutic action |
| PI15/00616 |
| Kohler -, Ralf |
| 01/01/2016 - 31/12/2018 |
| 87.250,00 € |
| ISC III |
| Analysis of protein/metabolites interactions in plasma serum using calorimetry: application as a quick and noninvasive diagnostic method for early detection and monitoring of tumor digestive diseases (DIGCAL) |
| PI15/00663 |
| Abián Franco, Olga María |
| 01/01/2016 - 31/12/2018 |
| 81.500,00 € |
| ISC III |
| Cornelia De Lange syndrome: development of diagnostic panels, gene expression patterns and evaluation of endocrine axes in affected patients |
| PI15/00707 |
| Ramos Fuentes, Feliciano |
| 01/01/2016 - 31/12/2018 |
| 99.500,00 € |
| ISC III |
| Cluster-randomized controlled hybrid trial evaluating the implementation and effectiveness of a complex multi-risk intervention to promote health-promoting behaviors in the population aged 45 to 75 years in Primary Care |
| PI15/00896 |
| Magallón Botaya, Rosa Mª |
| 01/01/2016 - 31/12/2018 |
| 24.200,00 € |
| ISC III |
| Preventing the onset of depression through a personalized intervention based on ICTs, risk prediction algorithms and decision support systems used by patients and GPs: the e-predictD |
| PI15/01035 |
| López Del Hoyo, Yolanda |
| 01/01/2016 - 30/11/2020 |
| 22.000,00 € |
| ISC III |
| Development and validation of epigenetic biomarkers in obstructive sleep apnea |
| PI15/01940 |
| Marín Trigo, José María |
| 01/01/2016 - 31/12/2018 |
| 135.500,00 € |
| ISC III |
| Identification of the genes responsible for severe FH in patients negative for LDLR, APOB, PCSK9 and APOE: exome sequencing and family segregation |
| PI15/01983 |
| Civeira Murillo, Fernando |
| 01/01/2016 - 30/06/2019 |
| 56.500,00 € |
| ISC III |
| Ambispective cohort of patients with OXA-48 type Carbapenemase Producing Enterobacteriaceae infections: clinical and microbiological study |
| PI14/01832 |
| Cloth Pardo, Jose Ramon |
| 01/01/2014 - 31/12/2016 |
| 51.050,00 € |
| ISC III |
| Early metabolic factors and cardiovascular disease in the absence of classic risk factors in national and international studies |
| PI14/00009 |
| Laclaustra Gimeno, Martin |
| 01/01/2015 - 31/12/2018 |
| 46.500,00 € |
| ISC III |
| NEW HIGHLY BIOACTIVE FORMULATIONS OF APO2L/TRAIL AS AN ANTI-TUMORAL TREATMENT |
| PI13/00416 |
| Martinez Lostao, Luis |
| 01/01/2014 - 30/06/2017 |
| 48.500,00 € |
| ISC III |
Title
Expedient
Principal Investigator
Duration
Amount
Funder
| Agreement between the Barcelona Supercomputing Center National Supercomputing Center and entities participating in the Data Science Program |
| IMP/00019 |
| Pablo Julvez, Luis Emilio |
| 03/12/2021 - 31/12/2023 |
| 21.633,33 € |
| ISC III |
| Agreement between the Red Biomedical Research Center, MP (CIBER) consortium and the Aragón Health Research Institute Foundation within the framework of the predictive medicine program, belonging to the precision medicine infrastructure associated with science and technology (IMPaCT) |
| IMP/00021 |
| Sons Larraz, Luis Alfonso |
| 22/12/2021 - 31/12/2023 |
| 233.909,94 € |
| ISC III |